Company: VCYT
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001384101-25-000060
Chunk: 32

Company: VERACYTE, INC.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 32
---
 as of March 31, 2025 are as follows (in thousands of dollars): Year Ending December 31,AmountsRemainder of 2025$6,148 20265,780 20278,388 20288,561 20298,246 Thereafter56,099 Total future minimum lease payments93,222 Less: amount representing interest42,721 Present value of future lease payments50,501 Less: short-term lease liabilities7,409 Long-term lease liabilities$43,092  The Company recognizes operating lease expense on a straight-line basis over the non-cancelable lease period. The following table summarizes operating lease expense and cash paid for amounts included in the measurement of lease liabilities (in thousands of dollars): Three Months Ended March 31,20252024Operating lease expense$2,254 $1,543 Cash paid for amounts included in the measurement of lease liabilities$1,922 $1,629 ContingenciesFrom time to time, the Company may be involved in various legal proceedings and claims arising in the ordinary course of business. Although the outcomes of such matters cannot be predicted with certainty, the Company believes there is no litigation pending that could have, either individually or in the aggregate, a material adverse impact on the Company's consolidated financial statements.On May 1, 2025, the Company filed a complaint in federal court in the Eastern District of Texas alleging that Sonic Healthcare USA, Inc., the healthcare company that offers ThyroSeq v3, is infringing three of the Company’s patents related to molecular testing of thyroid nodules. The complaint seeks treble damages, attorneys’ fees and costs as well as injunctive relief. Sonic Healthcare USA, Inc. has not yet responded to the Company’s complaint.

15

7. Stockholders’ Equity

 Common Stock The Company had reserved shares of common stock for issuance as follows:  March 31, 2025December 31, 2024Stock options and restricted stock units issued and outstanding6,135,010 5,773,382 Stock options and restricted stock units available for grant under stock option plans8,076,382 8,971,566 Common stock available for the Employee Stock Purchase Plan966,979 1,051,407 Total15,178,371 15,796,355 

8. Components of Other Income

Other income, net consists of the following (in thousands of dollars): Three Months Ended